Management of older patients with frailty and acute myeloid leukaemia: A British Society for Haematology good practice paper-Reference-Cited by-同舟云学术

Management of older patients with frailty and acute myeloid leukaemia: A British Society for Haematology good practice paper

Published:2022-08-24 Issue:2 Volume:199 Page:205-221
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Dennis Mike¹^ORCID,Copland Mhairi²^ORCID,Kaur Harpreet³,Kell Jonathan⁴,Nikolousis Emmanouil⁵,Mehta Priyanka⁶,Palanicawandar Renuka⁷,Potter Victoria⁸,Raj Kavita⁹,Thomas Ian¹⁰,Wilson Andrew¹¹^ORCID

Affiliation:

1. The Christie NHS Foundation Trust Manchester UK

2. Institute of Cancer Sciences University of Glasgow Glasgow UK

3. Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK

4. University Hospital of Wales Cardiff UK

5. The Clatterbridge Cancer Centre NHS Foundation Trust UK

6. University Hospitals of Bristol and Weston NHS Trust Bristol UK

7. Imperial College Healthcare NHS Trust London UK

8. King's College Hospital NHS Foundation Trust London UK

9. Guy's and St Thomas' NHS Foundation Trust London UK

10. Cardiff University Cardiff UK

11. University College London Hospitals NHS Foundation Trust London UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18369

Reference101 articles.

1. Age and acute myeloid leukemia

2. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

3. Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial

4. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

5. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCL-2 inhibition in haematological malignancies: Clinical application and complications;Blood Reviews;2024-05

2. Acute myeloid leukemia driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias;Haematologica;2024-01-04

3. A randomised evaluation of low‐dose cytosine arabinoside plus lenalidomide versus single‐agent low‐dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI‐1 trial;British Journal of Haematology;2023-11-28